SciELO - Scientific Electronic Library Online

 
vol.20 número2Programación fetal, estrés toxico intrauterino y consecuencias en el producto.Detección temprana : ¿El papanicolau es siempre la mejor opción? índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista de la Facultad de Medicina Humana

versão impressa ISSN 1814-5469versão On-line ISSN 2308-0531

Rev. Fac. Med. Hum. vol.20 no.2 Lima abr./jun 2020

http://dx.doi.org/10.25176/rfmh.v20i2.2295 

Letters

Are infections induced by NSAI?

Miguel A. Poma-Chávez1  , Human Medicine student

Julio Gutarra-Mendez1  , Human Medicine student

1Faculty of Human Medicine, Ricardo Palma University, Lima-Peru.

Mr. Editor:

Nonsteroidal anti-inflammatory drugs (NSAIDs) constitute a pharmacological family that shares antipyretic, analgesic and logically anti-inflammatory effects through their ability to inhibit the production of prostaglandin. The term non-steroidal refers to its effects similar to corticosteroids, but without the secondary consequences that are characteristic of steroids. The drugs that are included are varied, the most traditional being Ibuprofen, ASA, ketoprofen, ketorolac, Naproxen, among others1.

NSAIDs, as a whole, are ideal for treating pain, especially when it is secondary to inflammation. The free sale of some of them to the user, offers very satisfactory results in different types of episodes and therefore, currently, is one of the most prescribed and consumed pharmacological groups worldwide with a tendency to increase in the future due to the extension of its indications2. Due to this and consequently, it is necessary to know the safety aspects of NSAIDs in order to rationalize their consumption and prevent induced pathologies.

In this context, this year, the French Agency for the Safety of Medicines and Health Products (ANSM) presented a report motivated by the appearance of bacterial infections and found a possible association with the use of Ibuprofen and Ketoprofen, particularly in areas such as skin and other soft tissues such as pleuropulmonary and neurological. In France, various scientific societies are working on this issue, of which two of them consider it an important problem for public health. Studies suggest an association between NSAID exposure and an increased risk of pleuropulmonary complications, for example; pleural empyema (Odds rattio: 2.79); they also found an increased risk of suffering significant necrotizing soft tissue infections in cases of chickenpox (risk between 3.9-10.2)3.

The experimental data point to 3 phenomena that generate the underlying cause of the consumption of NSAIDs such as the masking of the symptoms of the infection, immunomodulatory effects (the recruitment of neutrophils is altered), and the spread of streptococcal infection (in particular with the use of ibuprofen). Experimental studies point to the existence of a real link that reaches levels of evidence that are worrying and high enough to take preventive measures3.

Considering that these are important preventable pathologies, and that, in certain cases they can lead to death, it is necessary that the authorities take actions in the framework of prevention, control of indiscriminate sale, and finally, as a recommendation to the professionals of the health, take great care in the prescription and consumption of Ibuprofen and Ketoprofen, taking into account that there are other less harmful alternatives.

REFERENCES

1. Loza E. AINE´´s en la práctica clínica: lo que hay que saber. 2011; Inf Ter Sist Nac Salud 35: 88-95 https://www.mscbs.gob.es/biblioPublic/publicaciones/ recursos_propios/infMedic/docs/vol35n3AINEs.pdf [ Links ]

2. Oscanoa-Espinoza Teodoro, Lizaraso-Soto Frank. Antiinflamatorios no esteroides: seguridad gastrointestinal, cardiovascular y renal. Rev. gastroenterol. Perú. 2015; 35( 1 ): 63-71. http://www.scielo.org.pe/scielo. php?script=sci_arttext&pid=S1022-51292015000100007&lng=es. [ Links ]

3. Anti-inflammatoires non stéroïdiens (AINS) et complications infectieuses graves - Point d'Information. Agencia Francesa para la Seguridad de Medicamentos y Productos Sanitarios. 2019. https://ansm.sante.fr/S-informer/ Points-d-information-Points-d-information/Anti-inflammatoires-nonsteroidiens- AINS-et-complications-infectieuses-graves-Point-d-Information/ (language)/fre-FR [ Links ]

Financing: Self-financed.

Received: October 01, 2019; Accepted: February 07, 2020

Correspondence: Miguel Ángel Poma. Address: Calle 10 N348 Urb Monterrico Norte, San Borja, Lima-Perú. Telephone: +51 964 780 352 E-mail:mapoma@pucp.pe

Authorship contributions: The authors participated in the generation, collection of information, writing and final version of the original article.

Conflict of interest: The authors declare that they have no conflicts of interest in the publication of this article.

Creative Commons License Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons